TCF7L2 and type 2 diabetes mellitus: Decreased TCF7L2 protein levels in T2DM correlated with the downregulation of GIP and GLP-1 receptors (GIP-R and GLP-1R), and impaired β-cell function [24, 25], lead to fasting and postprandial hyperglycaemia [26–28].